For instance, a lower ZHX1 expression was related to a better prognosis of patients without lymph node metastasis, whereas a higher ZHX1 expression was related to a better prognosis of patients without distant metastasis. This evidence concerns the gene ZHX1 and metastatic malignant neoplasm in the lymph nodes.